Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
628.43
643.15
658.98
844.69
718.38
596.98
547.57
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
628.43
643.15
658.98
844.69
718.38
596.98
547.57
Raw Material Cost
121.58
213.57
335.54
491.45
478.11
393.09
376.95
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.16
0.52
1.24
0.88
0.91
1.67
2.79
Selling and Distribution Expenses
424.83
382.76
280.71
311.16
203.06
173.21
141.12
Other Expenses
1.43
1.47
1.20
1.17
0.87
0.46
0.17
Total Expenditure (Excl Depreciation)
560.87
611.57
629.50
815.17
690.83
572.60
522.51
Operating Profit (PBDIT) excl Other Income
67.6
31.6
29.5
29.5
27.599999999999998
24.4
25.099999999999998
Other Income
51.98
34.27
18.61
28.21
26.79
27.08
27.81
Operating Profit (PBDIT)
135.69
83.73
70.57
82.07
76.36
65.66
61.56
Interest
0.16
0.52
1.24
0.88
0.91
1.67
2.79
Exceptional Items
-2.72
-0.71
-19.80
0.00
0.00
0.10
-0.12
Gross Profit (PBDT)
506.85
429.58
323.44
353.24
240.27
203.89
170.63
Depreciation
19.14
21.69
25.92
24.49
25.45
16.74
10.91
Profit Before Tax
113.67
60.81
23.60
56.70
50.01
47.35
47.74
Tax
20.55
12.92
7.87
10.59
6.54
6.26
10.41
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
92.58
45.93
15.39
44.14
42.48
41.09
37.33
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
92.58
45.93
15.39
44.14
42.48
41.09
37.33
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.54
1.53
0.34
1.98
1.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
93.12
47.46
15.73
46.12
43.47
41.09
37.33
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
816.02
739.00
745.02
745.29
717.39
687.15
652.17
Earnings per share (EPS)
0.5
0.25
0.08
0.23
0.22
0.22
0.2
Diluted Earnings per share
0.5
0.25
0.08
0.23
0.22
0.22
0.2
Operating Profit Margin (Excl OI)
10.27%
4.32%
3.95%
3.48%
3.36%
3.66%
4.17%
Gross Profit Margin
21.13%
12.83%
7.51%
9.61%
10.5%
10.74%
10.71%
PAT Margin
14.73%
7.14%
2.33%
5.23%
5.91%
6.88%
6.82%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -2.29% vs -2.41% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 96.00% vs 202.55% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 69.09% vs -4.81% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -60.00% vs -58.33% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Tibet Aim Pharm., Inc. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
628.43
0
628.43
Other Operating Income
0.00
0.00
0.00
Total Operating income
628.43
0
628.43
Raw Material Cost
121.58
0
121.58
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.16
0
0.16
Selling and Distribution Expenses
424.83
0
424.83
Other Expenses
1.43
0.00
1.43
Total Expenditure (Excl Depreciation)
560.87
0
560.87
Operating Profit (PBDIT) excl Other Income
67.56
0.00
67.56
Other Income
51.98
0
51.98
Operating Profit (PBDIT)
135.69
0
135.69
Interest
0.16
0
0.16
Exceptional Items
-2.72
0
-2.72
Gross Profit (PBDT)
506.85
0
506.85
Depreciation
19.14
0
19.14
Profit Before Tax
113.67
0
113.67
Tax
20.55
0
20.55
Provisions and contingencies
0
0
0.00
Profit After Tax
92.58
0
92.58
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
92.58
0
92.58
Share in Profit of Associates
0
0
0.00
Minority Interest
0.54
0
0.54
Other related items
0.00
0.00
0.00
Consolidated Net Profit
93.12
0
93.12
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
816.02
0
816.02
Earnings per share (EPS)
0.50
0
0.50
Diluted Earnings per share
0.50
0
0.50
Operating Profit Margin (Excl OI)
10.27%
0%
0.00
10.27%
Gross Profit Margin
21.13%
0%
0.00
21.13%
PAT Margin
14.73%
0%
0.00
14.73%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 62.84 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -2.29% vs -2.41% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 9.31 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 96.00% vs 202.55% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.37 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 69.09% vs -4.81% in Dec 2024
Annual - Interest
Interest 0.02 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -60.00% vs -58.33% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.27%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






